No price history available.

Based on consensus from external analysts. Not Kvantra's opinion.

Pantheon International PLC functions as an investment trust, primarily employing a fund-of-funds approach. It strategically deploys capital into a wide array of investment vehicles worldwide, encompassing private equity, buyout, venture capital, growth equity, secondary market funds, and special situations strategies. Within its private equity allocation, the firm spans the full range, from early-stage technology funds to late-stage buyout transactions. Geographically, Pantheon maintains a concentrated focus on North America, Asia, and Northern Europe, with particular attention paid to the United States. Its US investment strategy targets mid-market buyout funds, along with mature venture and growth equity opportunities. In Europe, the emphasis is on mid-market buyout funds, while Asian investments are predominantly directed towards growth and buyout strategies. The company prioritizes funds specializing in unlisted companies and the acquisition of unquoted asset portfolios. Furthermore, Pantheon actively engages in co-investments alongside private equity managers. Its comprehensive investment mandate permits the use of diverse financial instruments, including equity and non-equity shares, debt securities, subscription and conversion rights, options, and interests in various partnership structures or other collective investment schemes.

• Bure Equity AB (publ)
• HBM Healthcare Investments AG
• MFF Capital Investments Limited
• Corporación Financiera Colombiana S.A.
• Fairfax India Holdings Corporation
• Gimv N.V.
• The Law Debenture Corporation p.l.c.
• Tri-Continental Corporation PFD $2.50